These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 1966881

  • 1. Ground-glass hepatocytes: light and electron microscopy. Characterization of the different types.
    Vázquez JJ.
    Histol Histopathol; 1990 Jul; 5(3):379-86. PubMed ID: 1966881
    [Abstract] [Full Text] [Related]

  • 2. Lafora-like ground-glass inclusions in hepatocytes of pediatric patients: a report of two cases.
    O'Shea AM, Wilson GJ, Ling SC, Minassian BA, Turnbull J, Cutz E.
    Pediatr Dev Pathol; 2007 Jul; 10(5):351-7. PubMed ID: 17929993
    [Abstract] [Full Text] [Related]

  • 3. Ground-glass, polyglucosan-like hepatocellular inclusions: A "new" diagnostic entity.
    Lefkowitch JH, Lobritto SJ, Brown RS, Emond JC, Schilsky ML, Rosenthal LA, George DM, Cairo MS.
    Gastroenterology; 2006 Sep; 131(3):713-8. PubMed ID: 16952540
    [Abstract] [Full Text] [Related]

  • 4. Cyanamide-induced liver cell injury. Experimental study in the rat.
    Guillen FJ, Vazquez JJ.
    Lab Invest; 1984 Apr; 50(4):385-93. PubMed ID: 6323849
    [Abstract] [Full Text] [Related]

  • 5. Comparative study of the intracytoplasmic inclusions in Lafora disease and type IV glycogenosis by electron microscopy.
    Ishihara T, Yokota T, Yamashita Y, Takahashi M, Kawano H, Uchino F, Kamei T, Matsumoto N, Kusunose Y, Yamada M.
    Acta Pathol Jpn; 1987 Oct; 37(10):1591-601. PubMed ID: 2829501
    [Abstract] [Full Text] [Related]

  • 6. Regression mechanism of cyanamide-induced inclusion bodies in the rat: a useful experimental pattern to study the beta-glycogen metabolization of hepatocytes.
    Idoate MA, Vázquez JJ.
    Int J Exp Pathol; 1992 Dec; 73(6):699-708. PubMed ID: 1337264
    [Abstract] [Full Text] [Related]

  • 7. Cyanamide and its calcium form: do they differ with respect to their action on the liver cell? Experimental study in the rat.
    Valérdiz S, Vázquez JJ.
    Appl Pathol; 1989 Dec; 7(6):344-9. PubMed ID: 2640894
    [Abstract] [Full Text] [Related]

  • 8. Liver glycogen bodies: ground-glass hepatocytes in transplanted patients.
    Bejarano PA, Garcia MT, Rodriguez MM, Ruiz P, Tzakis AG.
    Virchows Arch; 2006 Nov; 449(5):539-45. PubMed ID: 17024424
    [Abstract] [Full Text] [Related]

  • 9. Lafora disease: diagnosis by liver biopsy.
    Nishimura RN, Ishak KG, Reddick R, Porter R, James S, Barranger JA.
    Ann Neurol; 1980 Oct; 8(4):409-15. PubMed ID: 6254436
    [Abstract] [Full Text] [Related]

  • 10. Appearance of sinusoidal inclusion-containing endothelial cells in liver disease.
    Iwamura S, Enzan H, Saibara T, Onishi S, Yamamoto Y.
    Hepatology; 1994 Sep; 20(3):604-10. PubMed ID: 7521315
    [Abstract] [Full Text] [Related]

  • 11. Ground-glass hepatocytes in fibrinogen storage disease in Japanese Black calves.
    Yamada M, Nakamura K, Nakajima Y, Yamamoto M, Komae H, Okuda K, Tsuji M, Arai M.
    J Comp Pathol; 2002 Sep; 126(2-3):95-9. PubMed ID: 11944997
    [Abstract] [Full Text] [Related]

  • 12. Adult polyglucosan body disease: a rare presentation with chronic liver disease and ground-glass hepatocellular inclusions.
    Hajdu CH, Lefkowitch JH.
    Semin Liver Dis; 2011 May; 31(2):223-9. PubMed ID: 21538287
    [Abstract] [Full Text] [Related]

  • 13. Use of a monoclonal antibody against Lafora bodies for the immunocytochemical study of ground-glass inclusions in hepatocytes due to cyanamide.
    Hashimoto K, Hoshii Y, Takahashi M, Mitsuno S, Hanai N, Watanabe Y, Ishihara T.
    Histopathology; 2001 Jul; 39(1):60-5. PubMed ID: 11454045
    [Abstract] [Full Text] [Related]

  • 14. Ground-glass hepatocellular inclusions are associated with polypharmacy.
    Lu HC, González IA, Byrnes K.
    Ann Diagn Pathol; 2021 Jun; 52():151740. PubMed ID: 33836412
    [Abstract] [Full Text] [Related]

  • 15. Hepatic disease associated with ground-glass inclusions in hepatocytes after cyanamide therapy.
    Bruguera M, Lamar C, Bernet M, Rodés J.
    Arch Pathol Lab Med; 1986 Oct; 110(10):906-10. PubMed ID: 3021086
    [Abstract] [Full Text] [Related]

  • 16. Viral and autoimmune hepatitis. Morphologic and pathogenetic aspects of cell damage in hepatitis with potential chronicity.
    Dienes HP.
    Veroff Pathol; 1989 Oct; 132():1-107. PubMed ID: 2524940
    [Abstract] [Full Text] [Related]

  • 17. Glycogen pseudoground glass change in hepatocytes.
    Wisell J, Boitnott J, Haas M, Anders RA, Hart J, Lewis JT, Abraham SC, Torbenson M.
    Am J Surg Pathol; 2006 Sep; 30(9):1085-90. PubMed ID: 16931952
    [Abstract] [Full Text] [Related]

  • 18. Axilla skin biopsy: a reliable test for the diagnosis of Lafora's disease.
    Busard HL, Gabreëls-Festen AA, Renier WO, Gabreëls FJ, Stadhouders AM.
    Ann Neurol; 1987 Jun; 21(6):599-601. PubMed ID: 3037993
    [Abstract] [Full Text] [Related]

  • 19. Ground-glass hepatocytes with Lafora body like inclusions--histochemical, immunohistochemical and electronmicroscopic characterization.
    Ng IO, Sturgess RP, Williams R, Portmann B.
    Histopathology; 1990 Aug; 17(2):109-15. PubMed ID: 2172143
    [Abstract] [Full Text] [Related]

  • 20. [Disappearance of Mallory bodies in the liver of autopsy cases with a history of heavy drinking].
    Iwaba A, Kishi M, Nakazawa H, Ogata S, Koike J, Aida Y, Maeyama S, Uchikoshi T.
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 1999 Jun; 34(3):153-60. PubMed ID: 10424110
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.